Trials / Unknown
UnknownNCT01962402
Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Southern California Institute for Research and Education · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lorcaserin | Patients will receive lorcaserin 10mg tablet, 1 tablet twice daily for 12 weeks. |
| BEHAVIORAL | Intensive dietary counseling | All patients in the study will receive intensive dietary counseling, encouraging eating minimal carbohydrates and sugars. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-07-01
- First posted
- 2013-10-14
- Last updated
- 2014-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01962402. Inclusion in this directory is not an endorsement.